[1]
H. R. . Fadhil, A. A. Al-Jumaili, and N. A. . Al-Ani, “Cost-effectiveness Analysis of Reference Infliximab (Remicade) Compared to its Biosimilar (Remsima) in Iraqi Patients with Rheumatoid Arthritis (Conference Paper )#”, Iraqi Journal of Pharmaceutical Sciences , vol. 31, no. Suppl., pp. 100–110, Feb. 2023, doi: 10.31351/vol31issSuppl.pp100-110.